Back to Screener

Healthcare

Innate Pharma S.A.(IPHYF)

Live Price

Offline

$1.65

+0.00% today

1Y Change

-15.38%

Window

Jun 26, 2025 β†’ Jun 23, 2026

Market Cap
$110.00M
Revenue Growth
-77.9%
EPS Growth
+9.8%
Dividend Yield
0.0%

Coverage: 248 bars Β· Jun 26, 2025 β†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Innate Pharma S.A. (IPHYF) is a Healthcare stock with a market cap of $110.00M and listed on OTC. The stock last traded around $1.65 and down 15.4% across the available one-year price window (Jun 26, 2025 β†’ Jun 23, 2026). Baseline metrics include revenue growth of -77.9%, EPS growth of +9.8%, a dividend yield of 0.0%. What stands out right now is revenue -77.9%, EPS +9.8%, free cash flow -625.6% with operating margin -2058.0% and ROIC -155.5%. Valuation already assumes a fairly strong business story at price/sales 40.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines IPHYF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IPHYF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

IPHYF

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

IPHYF Max Drawdown

-36.29%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for IPHYF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Next earningsSep 17, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
Sep 17, 26
TBD
β€”
Est -0.34
β€”
β€”
Est 7370.6B
β€”
Sep 17
β€”
May 13, 26
β€”
Est -0.35
β€”
β€”
Est 5755.1B
β€”
May 13
β€”
Sep 17, 25
βœ“
-0.29
Est -0.33
+12.4%
5722.4B
Est 1960.0B
+192.0%
Sep 17
β€”
May 12, 25
βœ—
-0.32
Est -0.26
-19.6%
285.8B
Est 17932.6B
-98.4%
May 12
β€”
Nov 13, 24
βœ—
-0.33
Est -0.30
-9.8%
13273.8B
Est 13281.9B
-0.1%
Nov 13
β€”
May 14, 24
βœ“
-0.13
Est -0.45
+71.5%
23582.1B
Est 18566.0B
+27.0%
May 14
β€”
Sep 14, 23
βœ—
0.02
Est 0.09
-74.4%
43852.3B
Est 69676.5B
-37.1%
Sep 14
β€”
Mar 23, 23
βœ—
-0.87
Est -0.42
-107.3%
8950.2B
Est 18406.9B
-51.4%
Mar 23
β€”
Nov 14, 22
βœ—
0.08
Est 0.39
-79.2%
43170.3B
Est 86040.8B
-49.8%
Nov 14
β€”
May 10, 22
βœ—
-0.41
Est -0.19
-121.1%
3166.5B
Est 26179.1B
-87.9%
May 10
β€”
Oct 26, 21
βœ—
-0.36
Est -0.30
-17.8%
11056.5B
Est 30523.3B
-63.8%
Oct 26
β€”
May 11, 21
βœ—
-0.83
Est -0.09
-828.8%
33102.1B
Est 69665.3B
-52.5%
May 11
β€”
Nov 17, 20
βœ—
-0.15
Est -0.08
-84.2%
33577.7B
Est 41183.1B
-18.5%
Nov 17
β€”
May 12, 20
βœ—
-0.59
Est -0.44
-34.0%
19726.2B
Est 19437.2B
+1.5%
May 12
β€”
Nov 13, 19
βœ“
0.23
Est -0.08
+387.5%
58577.3B
Est β€”
β€”
Nov 13
β€”
May 15, 19
0.36
Est β€”
β€”
84785.6B
Est β€”
β€”
May 15
β€”
Nov 15, 18
-0.30
Est β€”
β€”
26694.4B
Est β€”
β€”
Nov 15
β€”
May 16, 18
-0.54
Est β€”
β€”
26703.3B
Est β€”
β€”
May 16
β€”
Nov 15, 17
-0.49
Est β€”
β€”
24243.0B
Est β€”
β€”
Nov 15
β€”
May 15, 17
0.30
Est β€”
β€”
47240.0B
Est β€”
β€”
May 15
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener